Your email has been successfully added to our mailing list.

×
0 0 0 0.0922330097087378 0.0315533980582523 0.0113268608414239 0.0113268608414239 0.012135922330097
Stock impact report

Aclaris's drug to treat common growth on skin gets FDA nod [Reuters]

Aclaris Therapeutics, Inc. (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
Company Research Source: Reuters
Aclaris's drug to treat common growth on skin gets FDA nod | Reuters Reuters Staff 1 Min Read Dec 15 (Reuters) - Aclaris Therapeutics Inc said on Friday the U.S. Food and Drug Administration (FDA) had approved its topical drug to treat seborrheic keratoses, growths on the skin that are harmless but affect millions of Americans. Aclaris’s drug, Eskata, would be the first FDA-approved non-invasive treatment for the condition, the company said. Seborrheic keratoses are non-cancerous skin growths that affect more than 83 million adults in the United States, according to Aclaris. (Reporting by Divya Grover in Bengaluru; editing by Sai Sachin Ravikumar) All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2017 Reuters. All Rights Reserved. Aclaris's drug to treat common growth on skin gets FDA nod Dec 15 (Reuters) - Aclaris Therapeutics Inc said on Friday the U.S. Food and Drug Administration (FDA) had approved its topical drug to tre Show less Read more
Impact Snapshot
Event Time:
ACRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ACRS alerts
Opt-in for
ACRS alerts

from News Quantified
Opt-in for
ACRS alerts

from News Quantified